Ewl, I believe management will be putting out guidance figures shortly which should be interesting. All divisions performing to expectation - integration of the Healthpoint Data & Kiosk business going particularly well.
Realisation of the value of the Iridium asset still the wildcard, but QAD cheap at these prices.